Skip to content

Earnings yield at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
2.5%+0.3pp
Stryker logo
StrykerSYK
2.7%+0.6pp
Axogen logo
AxogenAXGN
-1.8%+61.8pp
Globus Medical logo
Globus MedicalGMED
5%+3.2pp
AbbVie logo
AbbVieABBV
0.9%-0.2pp
Medtronic logo
MedtronicMDT
4.6%+0.3pp

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

Based on trailing twelve months.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's earnings yield?
Integra LifeSciences (IART) reported earnings yield of -67.5% in Q1 2026.
What is the long-term trend for Integra LifeSciences's earnings yield?
Over 4 years (2020 to 2025), Integra LifeSciences's earnings yield has grown at a 116.4% compound annual growth rate (CAGR), from 2.4% to -53.4%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.